+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations

Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations

Human Genomics 6: 22

Pseudoexfoliation syndrome (PXS) is a systemic condition with eye manifestations. In the eye, pseudoexfoliation material deposits on various structures of the anterior segment. The nature of this material is mostly fibrillar with fibers made up of microfibrils and coated with amorphous material. The composition of these fibrils is diverse and includes basement membrane components as well as enzymes involved in extracellular matrix maintenance. Pseudoexfoliation is the most common cause of secondary open-angle glaucoma (pseudoexfoliation glaucoma, PXG) worldwide. The goal of this review is to summarize our knowledge on the genetics of this systemic disorder and its resultant ocular manifestations. PXS familial aggregation suggests genetic inheritance. PXS has been strongly associated with single nucleotide polymorphisms (SNPs) of the lysyl oxidase-like 1 (LOXL1) gene on chromosome 15q24.1. Two of these SNPs confer a higher than 99% population attributable risk for PXS and PXG in the Nordic population; however, they carry different risks in different populations. The high risk haplotypes also vary among different populations. LOXL1 is one of group of the enzymes involved in the cross-linking of collagen and elastin in the extracellular matrix. Its function in connective tissue maintenance has been confirmed in mice; however, its actual role in PXS remains unclear. Contactin-associated protein-like 2 also has a strong genetic association with PXS in a German cohort and is an attractive candidate molecule. It encodes for a protein involved in potassium channel trafficking. Other candidate genes linked to PXS include lysosomal trafficking regulator, clusterin, adenosine receptors, matrix metalloproteinase-1 (MMP1), and glutathione transferase. These genes may be modifying genes for development of PXS and PXG.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 036610210

Download citation: RISBibTeXText

PMID: 23157966

DOI: 10.1186/1479-7364-6-22

Related references

Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?. Archives of Ophthalmology 110(12): 1752-1756, 1992

Ocular and Systemic Pseudoexfoliation Syndrome. Yearbook of Ophthalmology 2007: 244-246, 2007

Ocular and systemic pseudoexfoliation syndrome. American Journal of Ophthalmology 141(5): 921-937, 2006

Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology 105(6): 951-968, 1998

Pseudoexfoliation syndrome (PEX)--a systemic disorder. Klinika Oczna 111(4-6): 160-164, 2009

Pseudoexfoliation syndrome Intraocular manifestation of a systemic disorder?. Experimental Eye Research 55(Suppl. 1): S68, 1992

Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey. International Journal of Ophthalmology 10(1): 128-134, 2017

Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 108(6): 1043-1049, 2001

Systemic high-sensitivity C-reactive protein level in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Journal of Glaucoma 19(6): 373-376, 2010

Systemic and ocular manifestations of the rubella syndrome. International Ophthalmology Clinics 12(2): 67-76, 1972

Ocular and systemic manifestations of exfoliation syndrome. Journal of Glaucoma 23(8 Suppl 1): S1-S8, 2015

Ocular and systemic manifestations of the Bardet-Biedl syndrome. American Journal of Ophthalmology 94(6): 750-756, 1982

Poster 67: Aarskog Syndrome: Ocular and Systemic Manifestations. Optometry - Journal of the American Optometric Association 78(6): 297-298, 2007

Ocular manifestations of some cranio-facial and systemic hereditary syndrome. First Inter-American Conference on Congenital Defects 1962 p 119-124, 1963

PHACE(S) syndrome: Report of a case with new ocular and systemic manifestations. Journal of Current Ophthalmology 29(2): 136-138, 2017